Aliases & Classifications for Pustulosis of Palm and Sole

MalaCards integrated aliases for Pustulosis of Palm and Sole:

Name: Pustulosis of Palm and Sole 12 15
Psoriasis 43 71
Pustular Psoriasis of the Palms and/or Soles 12
Acrodermatitis Continua of Hallopeau 71
Generalized Pustular Psoriasis 71
Pustulosis of Palms and Soles 71
Palmoplantar Pustulosis 12
Acropustulosis 12

Classifications:



External Ids:

Disease Ontology 12 DOID:4398
MeSH 43 D011565
NCIt 49 C34888
SNOMED-CT 67 27520001
ICD10 32 L40.3
UMLS 71 C0030246 C0033860 C0343055 more

Summaries for Pustulosis of Palm and Sole

MalaCards based summary : Pustulosis of Palm and Sole, also known as psoriasis, is related to impetigo herpetiformis and psoriasis 14, pustular, and has symptoms including pruritus, exanthema and psoriasiform rash. An important gene associated with Pustulosis of Palm and Sole is CCR6 (C-C Motif Chemokine Receptor 6), and among its related pathways/superpathways are PEDF Induced Signaling and Cytokine Signaling in Immune system. The drugs Esomeprazole and Dapsone have been mentioned in the context of this disorder. Affiliated tissues include skin, t cells and testes, and related phenotypes are hematopoietic system and immune system

Related Diseases for Pustulosis of Palm and Sole

Diseases related to Pustulosis of Palm and Sole via text searches within MalaCards or GeneCards Suite gene sharing:

(showing 1331, show less)
# Related Disease Score Top Affiliating Genes
1 impetigo herpetiformis 33.1 IL36RN IL1RL2 CARD14
2 psoriasis 14, pustular 33.0 IL36RN AP1S3
3 pustular psoriasis 32.9 TNF IL36RN AP1S3
4 geographic tongue 32.8 IL36RN IL1RL2 CARD14
5 pustulosis palmaris et plantaris 32.4 TNF IL36RN CCR6 AP1S3
6 systemic onset juvenile idiopathic arthritis 32.3 TNF IL1RN
7 chickenpox 30.7 TNFRSF1B TNF CCR6
8 necrobiosis lipoidica 30.6 TNFRSF1B TNF
9 enthesopathy 30.6 TNFRSF1B TNF MRAP CCR6
10 syphilis 30.5 MRAP IL17A CCR6
11 nail disease 30.5 TNFRSF1B TNF IL17A CCR6
12 cutaneous candidiasis 30.5 IL17A CCR6
13 tenosynovitis 30.4 TNFRSF1B TNF MRAP
14 synovitis 30.4 TNF IL1RN CXCL8
15 nasopharyngitis 30.4 TNFRSF1B TNF IL17A
16 lichen planus 30.4 TNF IL17A CXCL8
17 rheumatic disease 30.3 TNFRSF1B TNF IL1RN CCR6
18 rosacea 30.3 TNF CXCL8 CCR6
19 crohn's colitis 30.3 TNF CXCL8 CCR6
20 skin sarcoidosis 30.3 TNFRSF1B TNF
21 histoplasmosis 30.3 TNFRSF1B TNF CCR6
22 spondylitis 30.2 TNFRSF1B TNF IL1RN IL17A CCR6
23 acute generalized exanthematous pustulosis 30.2 IL36RN IL17A CXCL8
24 acquired immunodeficiency syndrome 30.2 TNFRSF1B TNF CCR6
25 ankylosis 30.1 TNFRSF1B TNF MRAP CCR6
26 sarcoidosis 1 30.1 TNFRSF1B TNF MRAP IL1RN CCR6
27 allergic contact dermatitis 30.1 TNF IL17A CXCL8
28 acrodermatitis 30.1 TNFRSF1B IL36RN IL1RL2 CARD14 AP1S3
29 childhood type dermatomyositis 30.0 TNFRSF1B TNF CCR6
30 bursitis 30.0 TNFRSF1B TNF MRAP
31 iridocyclitis 30.0 TNFRSF1B TNF MRAP IL17A
32 alopecia areata 30.0 TNF IL1RN IL17A
33 leukemia, acute monocytic 30.0 TNF SIGLEC5 CXCL8
34 iritis 30.0 TNFRSF1B TNF MRAP CCR6
35 neurofibromatosis, type ii 29.9 TNF SIGLEC5 IL1RN CXCL8 CCR6
36 meningitis 29.9 TNF IL17A CXCL8
37 posterior uveitis 29.9 TNF MRAP CCR6
38 tendinitis 29.9 TNFRSF1B TNF MRAP
39 chlamydia 29.9 TNF IL17A CXCL8
40 dermatitis 29.9 TNF IL17A CXCL8 CCR6
41 blepharitis 29.9 TNF CXCL8 CCR6
42 osteomyelitis 29.9 TNF LPIN2 IL1RN CXCL8
43 posterior scleritis 29.9 TNF MRAP
44 leprosy 3 29.8 TNF IL17A CXCL8 CCR6
45 candidiasis 29.8 TNF IL17A CXCL8
46 retinal vasculitis 29.8 TNFRSF1B MRAP CCR6
47 pharyngitis 29.8 TNFRSF1B TNF IL1RN CXCL8
48 mycobacterium tuberculosis 1 29.8 TNFRSF1B TNF IL17A CCR6
49 spondyloarthropathy 1 29.8 TNFRSF1B TNF MRAP IL1RN IL17A CCR6
50 nocardiosis 29.8 TNFRSF1B TNF
51 parasitic helminthiasis infectious disease 29.8 TNF SIGLEC5 IL17A CCR6
52 hair disease 29.8 TNF IL17A CCR6
53 birdshot chorioretinopathy 29.8 MRAP IL17A CCR6
54 coronary artery anomaly 29.7 TNFRSF1B TNF IL1RN CXCL8
55 colitis 29.7 TNF IL17A CXCL8 CCR6
56 reactive arthritis 29.7 TNF IL17A CXCL8 CCR6
57 familial mediterranean fever 29.7 TNF IL1RN IL17A
58 exanthem 29.7 TNFRSF1B TNF IL1RN CXCL8 CCR6
59 pneumocystosis 29.7 TNFRSF1B TNF CCR6
60 irritant dermatitis 29.7 TNF CXCL8
61 dermatitis herpetiformis 29.7 TNF IL17A CXCL8
62 stomatitis 29.7 TNF IL1RN CXCL8
63 alcoholic hepatitis 29.7 TNFRSF1B TNF CXCL8
64 palindromic rheumatism 29.7 TNFRSF1B TNF
65 contact dermatitis 29.7 TNF IL17A CXCL8
66 yellow fever 29.7 IL1RN IL17A CCR6
67 dermatitis, atopic 29.7 TNF SIGLEC5 IL17A CXCL8 CCR6
68 celiac disease 1 29.6 TNF IL17A CXCL8 CCR6
69 toxic shock syndrome 29.6 TNF IL1RN CXCL8
70 chronic recurrent multifocal osteomyelitis 29.6 TNF PSTPIP2 LPIN2 IL1RN
71 periodontitis 29.6 TNF IL1RN IL17A CXCL8
72 hypopyon 29.6 TNFRSF1B MRAP IL1RN IL17A
73 osteoarthritis 29.6 TNF IL1RN IL17A CXCL8
74 fasciitis 29.6 TNF IL1RN CXCL8
75 juvenile rheumatoid arthritis 29.6 TNFRSF1B TNF IL1RN CXCL8
76 ulcerative colitis 29.6 TNF IL1RN IL17A CXCL8 CCR6
77 bone inflammation disease 29.5 TNFRSF1B TNF MRAP IL1RN IL17A CXCL8
78 mumps 29.5 TNFRSF1B TNF CXCL8
79 urethritis 29.5 TNF MRAP CXCL8
80 psoriatic arthritis 29.5 TNFRSF1B TNF IL36RN IL1RN IL17A CCR6
81 cholangitis 29.5 TNF IL17A CXCL8
82 streptococcal toxic-shock syndrome 29.5 TNF CXCL8
83 uveitis 29.5 TNFRSF1B TNF IL17A CXCL8
84 periodic fever, familial, autosomal dominant 29.5 TNFRSF1B TNF IL1RN
85 chronic mucocutaneous candidiasis 29.5 TNF IL17A CCR6
86 chorioretinitis 29.5 TNFRSF1B TNF MRAP IL17A
87 peptic ulcer disease 29.5 TNF IL1RN CXCL8
88 interstitial lung disease 29.4 TNF IL17A CXCL8
89 allergic hypersensitivity disease 29.4 TNF IL17A CXCL8 CCR6
90 optic nerve disease 29.4 TNF IL17A CCR6
91 blastomycosis 29.4 TNF IL17A CCR6
92 crohn's disease 29.4 TNFRSF1B TNF IL17A CXCL8 CCR6
93 mycobacterium abscessus 29.4 TNF CXCL8
94 cryptococcosis 29.4 TNF IL17A CCR6
95 keratoconjunctivitis 29.4 TNF IL17A CXCL8
96 psoriasis 29.4 TNFRSF1B TNF IL36RN IL17A CXCL8 CCR6
97 oral candidiasis 29.4 IL1RN IL17A CXCL8 CCR6
98 collagen disease 29.3 TNF IL17A CCR6
99 arthritis 29.3 TNFRSF1B TNF IL1RN IL17A CXCL8 CCR6
100 pulmonary disease, chronic obstructive 29.3 TNF SIGLEC5 IL17A CXCL8 CCR6
101 pyoderma gangrenosum 29.3 TNF SIGLEC5 IL1RN CXCL8 CCR6
102 infective endocarditis 29.3 TNF SIGLEC5 IL17A
103 skin disease 29.3 TNFRSF1B TNF SIGLEC5 IL36RN IL17A CXCL8
104 keratitis, hereditary 29.3 TNF IL17A CXCL8 CCR6
105 neurosyphilis 29.3 IL17A CXCL8
106 aphthous stomatitis 29.3 TNF IL1RN CXCL8
107 autoimmune disease 29.3 TNFRSF1B TNF IL1RN IL17A CXCL8 CCR6
108 sapho syndrome 29.3 SIGLEC5 PSTPIP2 MRAP LPIN2 IL1RN CXCL8
109 pericarditis 29.3 TNF IL1RN CXCL8
110 endophthalmitis 29.3 TNF MRAP CXCL8
111 acute cystitis 29.2 TNF CXCL8 CCR6
112 common cold 29.2 TNF IL17A CXCL8 CCR6
113 pityriasis rubra pilaris 29.2 TNFRSF1B TNF LPIN2 IL36RN IL1RL2 IL17A
114 proteasome-associated autoinflammatory syndrome 1 29.2 TNFRSF1B TNF IL1RN IL17A CXCL8
115 vaginitis 29.2 TNF SIGLEC5 CXCL8 CCR6
116 macular retinal edema 29.2 TNFRSF1B TNF MRAP CXCL8
117 lymphadenitis 29.2 TNF CXCL8 CCR6
118 scleritis 29.2 TNFRSF1B TNF MRAP IL1RN CCR6
119 body mass index quantitative trait locus 11 29.2 TNFRSF1B TNF SIGLEC5 IL17A CXCL8 CCR6
120 corneal disease 29.2 TNF CXCL8 CCR6
121 gastroenteritis 29.2 TNF IL1RN CXCL8
122 pneumonia 29.1 TNFRSF1B TNF IL1RN IL17A CXCL8
123 peripheral nervous system disease 29.1 TNF IL17A CXCL8 CCR6
124 bacterial infectious disease 29.1 TNF IL1RN IL17A CXCL8 CCR6
125 endocarditis 29.1 TNFRSF1B TNF IL17A CXCL8
126 rhinitis 29.1 TNF IL17A CXCL8
127 granulomatosis with polyangiitis 29.1 TNFRSF1B TNF IL17A CCR6
128 adult-onset still's disease 29.1 TNF IL1RN CXCL8
129 multiple sclerosis 29.1 TNFRSF1B TNF IL1RN IL17A CXCL8 CCR6
130 gastroesophageal reflux 29.1 TNF IL1RN CXCL8
131 rheumatoid arthritis 29.1 TNFRSF1B TNF IL1RN IL17A CXCL8 CCR6
132 chronic fatigue syndrome 29.1 TNF IL17A CXCL8
133 aseptic meningitis 29.1 TNF IL1RN CXCL8
134 otitis media 29.0 TNF IL17A CXCL8
135 gastric ulcer 29.0 TNF IL1RN CXCL8
136 temporal arteritis 29.0 TNFRSF1B TNF IL1RN IL17A CCR6
137 chagas disease 29.0 TNF IL17A CXCL8
138 pyoderma 29.0 TNFRSF1B TNF SIGLEC5 IL36RN IL1RN CXCL8
139 transverse myelitis 29.0 TNF IL17A CXCL8
140 periostitis 29.0 MRAP LPIN2 IL36RN IL1RN IL1RL2 CARD14
141 bone disease 28.9 TNF IL17A CXCL8 CCR6
142 pulmonary fibrosis, idiopathic 28.9 TNF IL1RN IL17A CXCL8 CCR6
143 appendicitis 28.9 TNF IL17A CXCL8
144 bronchiolitis obliterans 28.9 TNF IL17A CXCL8
145 bronchiolitis 28.9 TNF IL17A CXCL8
146 relapsing-remitting multiple sclerosis 28.9 TNF IL1RN IL17A CXCL8 CCR6
147 cutaneous leishmaniasis 28.9 TNF IL17A CXCL8
148 aortitis 28.9 TNFRSF1B TNF MRAP IL1RN IL17A
149 myeloma, multiple 28.8 TNF IL17A CXCL8 CCR6
150 inflammatory bowel disease 28.8 TNFRSF1B TNF IL1RN IL17A CXCL8 CCR6
151 diabetes mellitus, insulin-dependent 28.8 TNF IL1RN IL17A CCR6
152 cryptogenic organizing pneumonia 28.8 TNF CXCL8
153 aspergillosis 28.8 TNFRSF1B TNF IL1RN CXCL8 CCR6
154 panuveitis 28.7 TNFRSF1B TNF MRAP IL1RN IL17A CCR6
155 myelitis 28.7 TNF IL17A CXCL8 CCR6
156 osteoporosis 28.7 TNFRSF1B TNF IL1RN IL17A CXCL8
157 mastitis 28.7 IL1RN IL17A CXCL8 CCR6
158 eye disease 28.7 TNF MRAP IL1RN IL17A CXCL8 CCR6
159 immune system disease 28.6 TNF SIGLEC5 IL17A CXCL8 CCR6
160 gastritis 28.6 TNF IL1RN IL17A CXCL8 CCR6
161 connective tissue disease 28.1 TNFRSF1B TNF SIGLEC5 MRAP IL1RN IL17A
162 behcet syndrome 27.7 TNFRSF1B TNF MRAP IL1RN IL17A CXCL8
163 psoriasis 13 12.7
164 psoriasis 7 12.7
165 psoriasis 11 12.7
166 psoriasis 2 12.6
167 psoriasis 15, pustular 12.6
168 psoriasis 4 12.6
169 psoriasis 3 12.6
170 psoriasis 10 12.6
171 psoriasis 6 12.6
172 psoriasis 5 12.5
173 psoriasis 12 12.5
174 psoriasis 8 12.5
175 psoriasis 9 12.5
176 mental retardation and psoriasis 12.3
177 tranebjaerg svejgaard syndrome 12.1
178 psoriatic juvenile idiopathic arthritis 11.9
179 psoriasis 1 11.7
180 parapsoriasis 11.5
181 vitiligo-associated multiple autoimmune disease susceptibility 1 11.5
182 subacute cutaneous lupus erythematosus 11.4
183 temporomandibular ankylosis 11.4
184 singleton-merten syndrome 1 11.2
185 rheumatoid factor-negative juvenile idiopathic arthritis 11.2
186 nail disorder, nonsyndromic congenital, 1 11.1
187 combined cellular and humoral immune defects with granulomas 11.1
188 immunodysregulation, polyendocrinopathy, and enteropathy, x-linked 11.1
189 singleton-merten syndrome 2 11.1
190 primary cutaneous amyloidosis 11.1
191 singleton-merten syndrome 11.1
192 polycystic kidney disease 10.7
193 skin carcinoma 10.6
194 hyperostosis 10.6
195 lipid metabolism disorder 10.6
196 vitiligo-associated multiple autoimmune disease susceptibility 6 10.6
197 inflammatory spondylopathy 10.6
198 scabies 10.6
199 bullous pemphigoid 10.5
200 tonsillitis 10.5
201 scleromalacia perforans 10.5 TNFRSF1B MRAP
202 disseminated chorioretinitis 10.5 TNFRSF1B MRAP
203 body mass index quantitative trait locus 1 10.5
204 chronic orbital inflammation 10.5 TNFRSF1B MRAP
205 anterior scleritis 10.5 TNFRSF1B MRAP
206 pompholyx 10.4
207 fatty liver disease 10.4
208 optic papillitis 10.4 TNFRSF1B MRAP
209 non-alcoholic fatty liver disease 10.4
210 acute retinal necrosis syndrome 10.4 SIGLEC5 MRAP
211 seborrheic dermatitis 10.4
212 metal allergy 10.4
213 hypereosinophilic syndrome 10.4
214 vascular disease 10.4
215 hepatitis c 10.4
216 atrophic glossitis 10.4 IL36RN IL1RL2
217 liver disease 10.4
218 atherosclerosis susceptibility 10.4
219 corneal dystrophy, band-shaped 10.4 TNFRSF1B MRAP
220 rheumatoid arthritis interstitial lung disease 10.4 TNFRSF1B TNF
221 neurodermatitis 10.4
222 basal cell carcinoma 10.4
223 ichthyosis 10.4
224 spondylarthropathy 10.4
225 severe combined immunodeficiency 10.3
226 ige responsiveness, atopic 10.3
227 herpes zoster 10.3
228 opportunistic bacterial infectious disease 10.3 TNFRSF1B TNF
229 macrophage activation syndrome 10.3 TNFRSF1B TNF
230 immune deficiency disease 10.3
231 neurosarcoidosis 10.3 TNFRSF1B TNF
232 body mass index quantitative trait locus 9 10.3
233 body mass index quantitative trait locus 8 10.3
234 body mass index quantitative trait locus 4 10.3
235 body mass index quantitative trait locus 10 10.3
236 body mass index quantitative trait locus 7 10.3
237 body mass index quantitative trait locus 12 10.3
238 body mass index quantitative trait locus 14 10.3
239 body mass index quantitative trait locus 18 10.3
240 body mass index quantitative trait locus 19 10.3
241 body mass index quantitative trait locus 20 10.3
242 skin atrophy 10.3
243 dermatophytosis 10.3
244 systemic lupus erythematosus 10.3
245 familial cold autoinflammatory syndrome 2 10.3 IL1RL2 CARD14
246 post-transplant lymphoproliferative disease 10.3 TNFRSF1B TNF
247 anxiety 10.3
248 hidradenitis 10.3
249 wissler's syndrome 10.3 TNFRSF1B IL1RN
250 squamous cell carcinoma 10.3
251 hidradenitis suppurativa 10.3
252 hansen's disease 10.3
253 arthropathy 10.3
254 alopecia 10.3
255 lymphopenia 10.3
256 depression 10.3
257 granulomatous dermatitis 10.3 TNFRSF1B TNF
258 vasculitis 10.3
259 alcohol dependence 10.3
260 alcohol use disorder 10.3
261 vulvar vestibulitis syndrome 10.3 TNF IL1RN
262 toxic megacolon 10.3 TNF CCR6
263 intermediate uveitis 10.3 TNF MRAP CCR6
264 hepatitis c virus 10.3
265 gout 10.3
266 diarrhea 10.3
267 hyperuricemia 10.3
268 kidney disease 10.3
269 melanoma 10.2
270 47,xyy 10.2
271 pars planitis 10.2 MRAP IL1RN CCR6
272 transient arthritis 10.2 MRAP IL17A
273 nevus, epidermal 10.2
274 alexithymia 10.2
275 papilloma 10.2
276 hypertriglyceridemia, familial 10.2
277 sleep apnea 10.2
278 hepatitis b 10.2
279 cinca syndrome 10.2 IL36RN IL1RN CCR6
280 autoimmune disease of cardiovascular system 10.2 TNF CCR6
281 lymphoma 10.2
282 dermatomyositis 10.2
283 amyloidosis 10.2
284 multinucleated neurons, anhydramnios, renal dysplasia, cerebellar hypoplasia, and hydranencephaly 10.2
285 systemic scleroderma 10.2
286 chronic kidney disease 10.2
287 klebsiella pneumonia 10.2 IL17A CCR6
288 uveoparotid fever 10.2 TNFRSF1B TNF
289 salmonellosis 10.2 TNF SIGLEC5 CCR6
290 arteries, anomalies of 10.2
291 hyperlipoproteinemia, type iii 10.2
292 sexual disorder 10.2
293 fissured tongue 10.2
294 hashimoto thyroiditis 10.2
295 mycosis fungoides 10.2
296 spondyloarthropathy 10.2
297 hypothyroidism 10.2
298 keratosis 10.2
299 iga glomerulonephritis 10.2
300 hypertrichosis 10.2
301 thyroid gland disease 10.2
302 thyroiditis 10.2
303 kaposi sarcoma 10.2
304 coronary heart disease 1 10.2
305 myocardial infarction 10.2
306 neutropenia 10.2
307 blood coagulation disease 10.2 TNF SIGLEC5 CCR6
308 good syndrome 10.2 TNFRSF1B TNF
309 palladium allergic contact dermatitis 10.2 TNF IL17A
310 fuchs' heterochromic uveitis 10.2 MRAP CXCL8
311 scleroderma, familial progressive 10.2
312 impotence 10.2
313 cerebrovascular disease 10.2
314 erythema elevatum diutinum 10.2 TNFRSF1B CXCL8
315 viral hepatitis 10.2
316 hepatitis 10.2
317 congestive heart failure 10.2
318 heart aneurysm 10.2 TNF IL1RN
319 hypercholesterolemia, familial, 1 10.1
320 retinal dystrophy, iris coloboma, and comedogenic acne syndrome 10.1
321 erythema multiforme 10.1
322 porokeratosis 10.1
323 inflammatory linear verrucous epidermal nevus 10.1
324 methotrexate toxicity 10.1
325 inflammatory bowel disease 18 10.1 IL17A CCR6
326 coronary aneurysm 10.1 TNF IL1RN
327 intestinal schistosomiasis 10.1 SIGLEC5 IL17A CCR6
328 graft-versus-host disease 10.1
329 hypoparathyroidism 10.1
330 idiopathic anterior uveitis 10.1 TNF CXCL8
331 cartilage disease 10.1 TNFRSF1B TNF IL1RN
332 telangiectasis 10.1
333 opisthorchiasis 10.1
334 demyelinating disease 10.1
335 cellulitis 10.1
336 sleep disorder 10.1
337 progressive multifocal leukoencephalopathy 10.1
338 pemphigus foliaceus 10.1
339 pericardium disease 10.1 TNFRSF1B TNF IL1RN
340 fibrosis of extraocular muscles, congenital, 1 10.1
341 rickets 10.1
342 thrombocytopenia 10.1
343 purpura 10.1
344 pityriasis rosea 10.1
345 mouth disease 10.1
346 human immunodeficiency virus type 1 10.1
347 bone mineral density quantitative trait locus 8 10.1
348 bone mineral density quantitative trait locus 15 10.1
349 peripheral vascular disease 10.1
350 cutaneous lupus erythematosus 10.1
351 sarcoma 10.1
352 glossitis 10.1
353 idiopathic interstitial pneumonia 10.1
354 pulmonary fibrosis 10.1
355 spindle cell sarcoma 10.1
356 b-cell lymphoma 10.1
357 discoid lupus erythematosus 10.1
358 haemophilus influenzae 10.1 TNF CXCL8
359 chemical colitis 10.1 TNF IL17A
360 toxicodendron dermatitis 10.1 TNF CXCL8
361 pneumonic tularemia 10.1 TNF IL17A CCR6
362 asthma 10.1
363 squamous cell papilloma 10.1
364 lung disease 10.1
365 pouchitis 10.1 IL1RN CXCL8
366 autoimmune disease of eyes, ear, nose and throat 10.1 TNF IL17A CCR6
367 lentigines 10.1
368 atrial fibrillation 10.1
369 tinea pedis 10.1
370 end stage renal failure 10.1
371 subcorneal pustular dermatosis 10.1
372 herpes simplex 10.1
373 measles 10.1
374 myositis 10.1
375 pemphigus vulgaris, familial 10.1
376 palmoplantar keratoderma, punctate type ii 10.1
377 dowling-degos disease 1 10.1
378 hypervitaminosis a 10.1
379 ocular motor apraxia 10.1
380 sjogren syndrome 10.1
381 helicobacter pylori infection 10.1
382 alpha/beta t-cell lymphopenia with gamma/delta t-cell expansion, severe cytomegalovirus infection, and autoimmunity 10.1
383 nail disorder, nonsyndromic congenital, 10 10.1
384 ataxia, combined cerebellar and peripheral, with hearing loss and diabetes mellitus 10.1
385 adult t-cell leukemia 10.1
386 cutaneous t cell lymphoma 10.1
387 psoriasis 15 10.1
388 sensorineural hearing loss 10.1
389 streptococcal meningitis 10.1
390 primary biliary cirrhosis 10.1
391 leukemia 10.1
392 haverhill fever 10.1
393 facial paralysis 10.1
394 urticaria 10.1
395 cheilitis 10.1
396 dental caries 10.1
397 relapsing polychondritis 10.1
398 glomerulonephritis 10.1
399 folliculitis 10.1
400 liver cirrhosis 10.1
401 hydrarthrosis 10.1
402 t-cell adult acute lymphocytic leukemia 10.1
403 conjunctivitis 10.1
404 t-cell leukemia 10.1
405 hyperthyroidism 10.1
406 impetigo 10.1
407 monocytic leukemia 10.1
408 lupus erythematosus 10.1
409 pemphigus 10.1
410 diabetes mellitus 10.1
411 neurofibroma 10.1
412 bacterial conjunctivitis 10.1
413 48,xyyy 10.1
414 acute monoblastic leukemia 10.1
415 cytokine deficiency 10.1
416 eosinophilic pustular folliculitis 10.1
417 guttate psoriasis 10.1
418 punctate porokeratosis 10.1
419 pik3ca-related overgrowth syndrome 10.1
420 autoimmune disease of urogenital tract 10.0 TNF IL17A CCR6
421 autoimmune disease of endocrine system 10.0 TNF IL17A CCR6
422 lymph node disease 10.0 TNF IL17A CCR6
423 spinal cord disease 10.0 TNF IL17A CCR6
424 salpingitis 10.0 TNF SIGLEC5
425 ileitis 10.0 TNF IL17A CCR6
426 autoimmune disease of gastrointestinal tract 10.0 TNF IL17A CCR6
427 extrinsic cardiomyopathy 10.0 TNF IL17A CCR6
428 ichthyosis vulgaris 10.0
429 neutrophil migration 10.0
430 kawasaki disease 10.0
431 non-alcoholic steatohepatitis 10.0
432 pancytopenia 10.0
433 epidermolysis bullosa 10.0
434 mood disorder 10.0
435 hyperglycemia 10.0
436 spongiotic dermatitis 10.0
437 actinic keratosis 10.0
438 bowen's disease 10.0
439 exfoliative dermatitis 10.0
440 splenomegaly 10.0
441 cardiac rupture 10.0 TNF CXCL8
442 angelucci's syndrome 10.0 IL17A CXCL8
443 renal cell carcinoma, nonpapillary 10.0
444 down syndrome 10.0
445 lung cancer 10.0
446 lymphoma, hodgkin, classic 10.0
447 dermatitis herpetiformis, familial 10.0
448 homocysteinemia 10.0
449 lymphoma, non-hodgkin, familial 10.0
450 microcephaly, epilepsy, and diabetes syndrome 10.0
451 deficiency anemia 10.0
452 paronychia 10.0
453 norwegian scabies 10.0
454 capillary leak syndrome 10.0
455 gonadal dysgenesis 10.0
456 hyperinsulinism 10.0
457 turner syndrome 10.0
458 secondary syphilis 10.0
459 epidermolysis bullosa acquisita 10.0
460 localized scleroderma 10.0
461 hypoglycemia 10.0
462 stevens-johnson syndrome/toxic epidermal necrolysis 10.0
463 lymphatic system disease 10.0 TNF IL17A CCR6
464 dental pulp disease 10.0 TNF CXCL8 CCR6
465 chronic conjunctivitis 10.0 TNF CXCL8 CCR6
466 cecal disease 10.0 TNF CXCL8 CCR6
467 pyelitis 10.0 TNF CXCL8 CCR6
468 colorectal cancer 10.0
469 benign chronic pemphigus 10.0
470 small cell cancer of the lung 10.0
471 allergic rhinitis 10.0
472 membranous nephropathy 10.0
473 tetanus 10.0
474 pulmonary sarcoidosis 10.0
475 polyneuropathy 10.0
476 cholecystitis 10.0
477 acute kidney failure 10.0
478 neuropathy 10.0
479 pulpitis 10.0 TNF CXCL8 CCR6
480 perinatal necrotizing enterocolitis 10.0 TNF CXCL8 CCR6
481 middle ear disease 10.0 TNF CXCL8 CCR6
482 dysentery 10.0 TNF CXCL8 CCR6
483 anus disease 10.0 TNF CXCL8 CCR6
484 viral encephalitis 10.0 TNF CXCL8 CCR6
485 blood group, globoside system 10.0 TNF MRAP CXCL8
486 bone sarcoma 10.0 IL1RN CXCL8
487 juvenile ankylosing spondylitis 10.0 TNFRSF1B TNF MRAP IL1RN
488 hypotrichosis 1 10.0 TNF CXCL8 CCR6
489 chondromalacia 10.0 TNFRSF1B TNF MRAP IL1RN
490 triiodothyronine receptor auxiliary protein 10.0
491 periodontitis, chronic 10.0
492 major affective disorder 8 10.0
493 major affective disorder 9 10.0
494 diffuse alopecia areata 10.0
495 heart disease 10.0
496 nephrotic syndrome 10.0
497 personality disorder 10.0
498 mental depression 10.0
499 bipolar disorder 10.0
500 myeloid leukemia 10.0
501 pleural disease 10.0 TNF CXCL8 CCR6
502 tuberculous meningitis 9.9 TNF CXCL8
503 endometrial disease 9.9 TNF SIGLEC5 CXCL8
504 endometritis 9.9 TNF SIGLEC5 CXCL8
505 endocardium disease 9.9 TNF SIGLEC5 CXCL8
506 atrial standstill 1 9.9
507 hepatocellular carcinoma 9.9
508 lichen sclerosus et atrophicus 9.9
509 migraine with or without aura 1 9.9
510 porokeratosis 1, multiple types 9.9
511 alopecia universalis congenita 9.9
512 taqi polymorphism 9.9
513 leukemia, chronic myeloid 9.9
514 angina pectoris 9.9
515 restless legs syndrome 9.9
516 mucositis 9.9
517 osteomalacia 9.9
518 glucose intolerance 9.9
519 diphtheria 9.9
520 tinea corporis 9.9
521 cholestasis 9.9
522 avoidant personality disorder 9.9
523 autoimmune hepatitis 9.9
524 vaccinia 9.9
525 mesangial proliferative glomerulonephritis 9.9
526 human immunodeficiency virus infectious disease 9.9
527 combined t cell and b cell immunodeficiency 9.9
528 cataract 9.9
529 scarlet fever 9.9
530 molluscum contagiosum 9.9
531 hard palate cancer 9.9
532 erythrokeratoderma ''en cocardes'' 9.9
533 pityriasis lichenoides 9.9
534 back pain 9.9
535 chlamydia pneumonia 9.9 TNF CXCL8
536 coccidiosis 9.9 TNF MRAP IL17A CCR6
537 primary systemic mycosis 9.9 TNFRSF1B TNF IL17A CCR6
538 breast cancer 9.9
539 hypertension, essential 9.9
540 neurofibromatosis, type iv, of riccardi 9.9
541 schizophrenia 9.9
542 thrombophilia due to thrombin defect 9.9
543 epidermodysplasia verruciformis 1 9.9
544 insulin-like growth factor i 9.9
545 gallbladder disease 1 9.9
546 kala-azar 1 9.9
547 severe cutaneous adverse reaction 9.9
548 leukemia, acute lymphoblastic 3 9.9
549 thrombosis 9.9
550 bone resorption disease 9.9
551 erysipelas 9.9
552 dilated cardiomyopathy 9.9
553 balanitis 9.9
554 porphyria 9.9
555 disease of mental health 9.9
556 clear cell acanthoma 9.9
557 acanthoma 9.9
558 hypogonadism 9.9
559 kidney cancer 9.9
560 pulmonary tuberculosis 9.9
561 scalp dermatosis 9.9
562 keratoacanthoma 9.9
563 ischemia 9.9
564 palmoplantar keratosis 9.9
565 granuloma annulare 9.9
566 proliferative glomerulonephritis 9.9
567 hypogonadotropism 9.9
568 gastrointestinal system disease 9.9
569 influenza 9.9
570 eating disorder 9.9
571 leishmaniasis 9.9
572 eczema herpeticum 9.9
573 acute graft versus host disease 9.9
574 frontal fibrosing alopecia 9.9
575 pityriasis lichenoides chronica 9.9
576 pseudoainhum 9.9
577 chronic actinic dermatitis 9.9
578 erythema multiforme major 9.9
579 overgrowth syndrome 9.9
580 mycetoma 9.9 IL17A CXCL8
581 splenic disease 9.9 TNF SIGLEC5 IL17A CCR6
582 pleurisy 9.8 TNF IL1RN CXCL8
583 acroosteolysis 9.8
584 annular erythema 9.8
585 alopecia, androgenetic, 1 9.8
586 myasthenia gravis 9.8
587 stroke, ischemic 9.8
588 resting heart rate, variation in 9.8
589 fatty liver disease, nonalcoholic 1 9.8
590 leptin deficiency or dysfunction 9.8
591 hydrops, lactic acidosis, and sideroblastic anemia 9.8
592 gastrointestinal ulceration, recurrent, with dysfunctional platelets 9.8
593 androgenic alopecia 9.8
594 pollen allergy 9.8
595 spinal disease 9.8
596 autosomal recessive congenital ichthyosis 9.8
597 lymphoproliferative syndrome 9.8
598 anogenital venereal wart 9.8
599 polycystic ovary syndrome 9.8
600 guillain-barre syndrome 9.8
601 cardiovascular system disease 9.8
602 keratoconjunctivitis sicca 9.8
603 focal segmental glomerulosclerosis 9.8
604 megaloblastic anemia 9.8
605 generalized anxiety disorder 9.8
606 retinal vein occlusion 9.8
607 arteriosclerosis 9.8
608 iron metabolism disease 9.8
609 acute pancreatitis 9.8
610 adenocarcinoma 9.8
611 gingivitis 9.8
612 aortic aneurysm 9.8
613 myopathy 9.8
614 uremia 9.8
615 poliomyelitis 9.8
616 pancreatitis 9.8
617 chronic inflammatory demyelinating polyradiculoneuropathy 9.8
618 demyelinating polyneuropathy 9.8
619 bronchitis 9.8
620 diffuse idiopathic skeletal hyperostosis 9.8
621 monoclonal gammopathy of uncertain significance 9.8
622 placenta disease 9.8
623 septic arthritis 9.8
624 subacute delirium 9.8
625 skin melanoma 9.8
626 pityriasis versicolor 9.8
627 pulmonary embolism 9.8
628 keloid disorder 9.8
629 chronic graft versus host disease 9.8
630 autonomic dysfunction 9.8
631 cytomegalovirus infection 9.8
632 paresthesia 9.8
633 rapidly involuting congenital hemangioma 9.8
634 lymphedema 9.8
635 x-linked intellectual disability-macrocephaly-macroorchidism syndrome 9.8
636 thyroid carcinoma 9.8
637 bacterial vaginosis 9.8 TNF IL1RN CXCL8
638 chorioamnionitis 9.8 TNF IL1RN CXCL8
639 duodenal ulcer 9.8 TNF IL1RN CXCL8
640 atrophic gastritis 9.8 TNF IL1RN CXCL8
641 apnea, obstructive sleep 9.8
642 porphyria cutanea tarda 9.8
643 keratosis, seborrheic 9.8
644 anemia, autoimmune hemolytic 9.8
645 myeloperoxidase deficiency 9.8
646 netherton syndrome 9.8
647 pituitary adenoma, prolactin-secreting 9.8
648 leukemia, acute myeloid 9.8
649 branchiootic syndrome 1 9.8
650 huntington disease-like 3 9.8
651 major depressive disorder 9.8
652 cone-rod synaptic disorder, congenital nonprogressive 9.8
653 lung cancer susceptibility 3 9.8
654 alpha-1-antitrypsin deficiency 9.8
655 hypophosphatemia 9.8
656 hyperphosphatemia 9.8
657 extrapulmonary tuberculosis 9.8
658 lymphocytic leukemia 9.8
659 pre-eclampsia 9.8
660 fanconi syndrome 9.8
661 lepromatous leprosy 9.8
662 myiasis 9.8
663 pulmonary edema 9.8
664 mitral valve insufficiency 9.8
665 conn's syndrome 9.8
666 optic neuritis 9.8
667 common variable immunodeficiency 9.8
668 secondary hyperparathyroidism 9.8
669 acute kidney tubular necrosis 9.8
670 dementia 9.8
671 hyperparathyroidism 9.8
672 eclampsia 9.8
673 frozen shoulder 9.8
674 oligospermia 9.8
675 panniculitis 9.8
676 thrombocytopenia due to platelet alloimmunization 9.8
677 neuritis 9.8
678 calcinosis 9.8
679 drug-induced hepatitis 9.8
680 thrombocytosis 9.8
681 central retinal vein occlusion 9.8
682 agammaglobulinemia 9.8
683 hairy cell leukemia 9.8
684 cryoglobulinemia 9.8
685 substance abuse 9.8
686 lipomatosis 9.8
687 mammary paget's disease 9.8
688 verrucous carcinoma 9.8
689 pseudohypoparathyroidism 9.8
690 hemolytic anemia 9.8
691 fibromyalgia 9.8
692 inverted follicular keratosis 9.8
693 polycythemia 9.8
694 in situ carcinoma 9.8
695 irritable bowel syndrome 9.8
696 hemophilia 9.8
697 central serous chorioretinopathy 9.8
698 granulocytopenia 9.8
699 homologous wasting disease 9.8
700 leukoplakia 9.8
701 oral lichen planus 9.8
702 polymyositis 9.8
703 superficial spreading melanoma 9.8
704 raynaud phenomenon 9.8
705 familial pityriasis rubra pilaris 9.8
706 aneurysm 9.8
707 chronic pain 9.8
708 headache 9.8
709 pituitary tumors 9.8
710 posttransplant acute limbic encephalitis 9.8
711 inflammatory myopathy with abundant macrophages 9.8
712 anti-p200 pemphigoid 9.8
713 epidermal disease 9.8
714 autoinflammatory syndrome 9.8
715 viral pneumonia 9.8 TNF IL17A CXCL8
716 histiocytosis 9.8 TNF IL1RN IL17A CCR6
717 streptococcus pneumonia 9.8 TNF IL17A CXCL8
718 amebiasis 9.8 TNF IL17A CXCL8
719 churg-strauss syndrome 9.8 TNF IL17A CXCL8
720 cystitis 9.7 TNF IL17A CXCL8
721 bacterial meningitis 9.7 TNF IL17A CXCL8
722 mevalonic aciduria 9.7 TNFRSF1B LPIN2 IL1RN IL1RL2 CARD14
723 bacterial sepsis 9.7 TNF IL1RN CXCL8 CCR6
724 food allergy 9.7 TNF IL17A CXCL8
725 aortic aneurysm, familial abdominal, 1 9.7
726 acanthosis nigricans 9.7
727 arthritis, sacroiliac 9.7
728 epidermolytic hyperkeratosis 9.7
729 cardiac arrhythmia 9.7
730 cardiac conduction defect 9.7
731 hypercarotenemia and vitamin a deficiency, autosomal dominant 9.7
732 darier-white disease 9.7
733 factor viii deficiency 9.7
734 lymphoma, mucosa-associated lymphoid type 9.7
735 geographic and fissured tongue 9.7
736 leukemia, chronic lymphocytic 9.7
737 prostate cancer 9.7
738 pulmonary hypertension, primary, 1 9.7
739 thrombocytopenic purpura, autoimmune 9.7
740 thyroid cancer, nonmedullary, 1 9.7
741 tobacco addiction 9.7
742 arterial calcification, generalized, of infancy, 1 9.7
743 hemochromatosis, type 1 9.7
744 myelofibrosis 9.7
745 polycythemia vera 9.7
746 xeroderma pigmentosum, variant type 9.7
747 hemophilia a 9.7
748 aging 9.7
749 macular degeneration, age-related, 1 9.7
750 dermatitis, atopic, 2 9.7
751 huntington disease-like 2 9.7
752 aplastic anemia 9.7
753 smoking as a quantitative trait locus 3 9.7
754 acute promyelocytic leukemia 9.7
755 microvascular complications of diabetes 3 9.7
756 microvascular complications of diabetes 4 9.7
757 microvascular complications of diabetes 6 9.7
758 microvascular complications of diabetes 7 9.7
759 osteomyelitis, sterile multifocal, with periostitis and pustulosis 9.7
760 myelodysplastic syndrome 9.7
761 pulmonary fibrosis and/or bone marrow failure, telomere-related, 2 9.7
762 aortic valve disease 2 9.7
763 chronic ulcer of skin 9.7
764 autoimmune uveitis 9.7
765 chikungunya 9.7
766 diffuse large b-cell lymphoma 9.7
767 marginal zone b-cell lymphoma 9.7
768 secondary progressive multiple sclerosis 9.7
769 follicular lymphoma 9.7
770 immunoglobulin alpha deficiency 9.7
771 ductal carcinoma in situ 9.7
772 lymphocytic colitis 9.7
773 angular cheilitis 9.7
774 zika fever 9.7
775 latex allergy 9.7
776 venous insufficiency 9.7
777 dry eye syndrome 9.7
778 osteonecrosis 9.7
779 cholelithiasis 9.7
780 charcot-marie-tooth disease 9.7
781 interstitial nephritis 9.7
782 renal hypertension 9.7
783 portal hypertension 9.7
784 thrombotic thrombocytopenic purpura 9.7
785 filariasis 9.7
786 hand, foot and mouth disease 9.7
787 tooth disease 9.7
788 lipoid nephrosis 9.7
789 discitis 9.7
790 respiratory failure 9.7
791 keratomalacia 9.7
792 epidural abscess 9.7
793 tinea cruris 9.7
794 pulmonary alveolar proteinosis 9.7
795 goiter 9.7
796 vogt-koyanagi-harada disease 9.7
797 balanoposthitis 9.7
798 acquired hyperkeratosis 9.7
799 tinea manuum 9.7
800 alcoholic liver cirrhosis 9.7
801 autoimmune polyendocrine syndrome 9.7
802 prostatitis 9.7
803 chromoblastomycosis 9.7
804 dermatomycosis 9.7
805 conjunctival squamous cell carcinoma 9.7
806 telogen effluvium 9.7
807 exostosis 9.7
808 hereditary multiple exostoses 9.7
809 constipation 9.7
810 vulvovaginitis 9.7
811 psychotic disorder 9.7
812 transitional cell carcinoma 9.7
813 bruxism 9.7
814 membranoproliferative glomerulonephritis 9.7
815 gingival overgrowth 9.7
816 fibrosarcoma 9.7
817 mixed connective tissue disease 9.7
818 mastocytosis 9.7
819 thrombophlebitis 9.7
820 vulvitis 9.7
821 thyroid gland papillary carcinoma 9.7
822 heart valve disease 9.7
823 primary syphilis 9.7
824 coronary stenosis 9.7
825 superficial basal cell carcinoma 9.7
826 cutaneous fibrous histiocytoma 9.7
827 neurotic disorder 9.7
828 elephantiasis 9.7
829 adjustment disorder 9.7
830 aortic valve insufficiency 9.7
831 eosinophilic pneumonia 9.7
832 adenoma 9.7
833 peritonitis 9.7
834 multiple carboxylase deficiency 9.7
835 intermediate coronary syndrome 9.7
836 erythematosquamous dermatosis 9.7
837 visceral leishmaniasis 9.7
838 splenic tuberculosis 9.7
839 lipid storage disease 9.7
840 plantar fasciitis 9.7
841 myotonic dystrophy 9.7
842 hereditary multiple osteochondromas 9.7
843 hypertrophic cardiomyopathy 9.7
844 sickle cell disease 9.7
845 acquired hemophilia 9.7
846 al amyloidosis 9.7
847 allergic encephalomyelitis 9.7
848 amyloidosis aa 9.7
849 carcinoid syndrome 9.7
850 carcinoma showing thymus-like differentiation 9.7
851 ichthyosis, acquired 9.7
852 linear lichen planus 9.7
853 mycobacterium marinum 9.7
854 prurigo nodularis 9.7
855 pyogenic granuloma 9.7
856 streptococcal group a invasive disease 9.7
857 sudden sensorineural hearing loss 9.7
858 b-cell non-hodgkin lymphoma 9.7
859 systemic autoimmune disease 9.7
860 autosomal dominant epidermolytic ichthyosis 9.7
861 avascular necrosis 9.7
862 iga pemphigus 9.7
863 acute liver failure 9.7
864 hyperpigmentation of the skin 9.7
865 glomerular disease 9.7
866 primary adrenal insufficiency 9.7
867 cutaneous myiasis 9.7
868 clonorchiasis 9.7 TNF CXCL8
869 lichen disease 9.6 TNF IL17A CXCL8 CCR6
870 lacrimal apparatus disease 9.6 TNF IL17A CXCL8 CCR6
871 vaginal disease 9.6 TNF IL17A CXCL8 CCR6
872 rectal disease 9.6 TNF IL17A CXCL8 CCR6
873 opportunistic mycosis 9.6 TNF IL17A CXCL8 CCR6
874 nasal cavity disease 9.6 TNF IL17A CXCL8 CCR6
875 paranasal sinus disease 9.6 TNF IL17A CXCL8 CCR6
876 nose disease 9.6 TNF IL17A CXCL8 CCR6
877 respiratory allergy 9.6 TNF IL17A CXCL8 CCR6
878 commensal bacterial infectious disease 9.6 TNF IL17A CXCL8 CCR6
879 bacterial pneumonia 9.6 TNF IL17A CXCL8 CCR6
880 autoimmune disease of central nervous system 9.6 TNF IL17A CXCL8 CCR6
881 upper respiratory tract disease 9.6 TNF IL17A CXCL8 CCR6
882 central nervous system vasculitis 9.6 TNFRSF1B TNF IL1RN IL17A CCR6
883 muscular disease 9.6 TNFRSF1B TNF MRAP CXCL8 CCR6
884 acrokeratosis verruciformis 9.5
885 ainhum 9.5
886 basal cell nevus syndrome 9.5
887 bladder cancer 9.5
888 leukocyte adhesion deficiency, type i 9.5
889 charcot-marie-tooth disease, demyelinating, type 1a 9.5
890 cleft palate, isolated 9.5
891 cleidocranial dysplasia 9.5
892 cryoglobulinemia, familial mixed 9.5
893 diabetes mellitus, noninsulin-dependent 9.5
894 dupuytren contracture 9.5
895 dyschromatosis symmetrica hereditaria 9.5
896 epidermoid cysts 9.5
897 pilomatrixoma 9.5
898 fanconi renotubular syndrome 1 9.5
899 felty syndrome 9.5
900 hair whorl 9.5
901 attention deficit-hyperactivity disorder 9.5
902 hypercalciuria, absorptive, 2 9.5
903 palmoplantar keratoderma, epidermolytic 9.5
904 immunoglobulin e concentration, serum 9.5
905 keloid formation 9.5
906 leiomyoma, uterine 9.5
907 lipomatosis, multiple 9.5
908 mastocytosis, cutaneous 9.5
909 melkersson-rosenthal syndrome 9.5
910 metaphyseal chondrodysplasia, schmid type 9.5
911 myelopathy, htlv-1-associated 9.5
912 neuropathy, hereditary, with liability to pressure palsies 9.5
913 noonan syndrome 1 9.5
914 ovarian cancer 9.5
915 paget disease, extramammary 9.5
916 parkinson disease, late-onset 9.5
917 polykaryocytosis inducer 9.5
918 actinic prurigo 9.5
919 pulmonary hemosiderosis 9.5
920 neural tube defects 9.5
921 spondyloarthropathy 2 9.5
922 strabismus 9.5
923 chromosome 2q35 duplication syndrome 9.5
924 syringomyelia, noncommunicating isolated 9.5
925 thrombophilia due to activated protein c resistance 9.5
926 digeorge syndrome 9.5
927 trigeminal neuralgia 9.5
928 urate oxidase, pseudogene 9.5
929 varicose veins 9.5
930 whim syndrome 9.5
931 wilms tumor 1 9.5
932 adrenocortical carcinoma, hereditary 9.5
933 alkaptonuria 9.5
934 chondrodysplasia punctata syndrome 9.5
935 chondrosarcoma 9.5
936 pituitary adenoma 4, acth-secreting 9.5
937 eosinophilic fasciitis 9.5
938 goodpasture syndrome 9.5
939 hutterite cerebroosteonephrodysplasia syndrome 9.5
940 hypoadrenocorticism, familial 9.5
941 acetylation, slow 9.5
942 moyamoya disease 1 9.5
943 holocarboxylase synthetase deficiency 9.5
944 myxedema 9.5
945 pulmonic stenosis 9.5
946 retinitis pigmentosa 9.5
947 short stature-obesity syndrome 9.5
948 tardive dyskinesia 9.5
949 restrictive dermopathy, lethal 9.5
950 tinea imbricata 9.5
951 werner syndrome 9.5
952 wilson disease 9.5
953 hypomelanosis of ito 9.5
954 chondrodysplasia punctata 2, x-linked dominant 9.5
955 congenital hemidysplasia with ichthyosiform erythroderma and limb defects 9.5
956 ichthyosis, x-linked 9.5
957 incontinentia pigmenti 9.5
958 glaucoma-related pigment dispersion syndrome 9.5
959 wilms tumor 5 9.5
960 autoimmune lymphoproliferative syndrome 9.5
961 malignant atrophic papulosis 9.5
962 ossification of the posterior longitudinal ligament of spine 9.5
963 acromelic frontonasal dysostosis 9.5
964 sickle cell anemia 9.5
965 reflex sympathetic dystrophy 9.5
966 brooke-spiegler syndrome 9.5
967 systemic lupus erythematosus 3 9.5
968 abdominal obesity-metabolic syndrome 1 9.5
969 dermatitis, atopic, 3 9.5
970 dermatitis, atopic, 4 9.5
971 dermatitis, atopic, 5 9.5
972 alveolar soft part sarcoma 9.5
973 nasopharyngeal carcinoma 9.5
974 creatinine clearance quantitative trait locus 9.5
975 dermatofibrosarcoma protuberans 9.5
976 hypertensive nephropathy 9.5
977 neutrophilic dermatosis, acute febrile 9.5
978 autoimmune disease 3 9.5
979 legionnaire disease 9.5
980 lung cancer susceptibility 1 9.5
981 chilblain lupus 1 9.5
982 intraocular pressure quantitative trait locus 9.5
983 celiac disease 6 9.5
984 peripapillary atrophy, beta type 9.5
985 lipoprotein glomerulopathy 9.5
986 diabetes mellitus, ketosis-prone 9.5
987 myd88 deficiency 9.5
988 inflammatory bowel disease 17 9.5
989 microvascular complications of diabetes 5 9.5
990 trichotillomania 9.5
991 dermatitis, atopic, 9 9.5
992 ectodermal dysplasia-syndactyly syndrome 2 9.5
993 gastric cancer 9.5
994 okt4 epitope deficiency 9.5
995 cfhr5 deficiency 9.5
996 human herpesvirus 8 9.5
997 erythroderma, congenital, with palmoplantar keratoderma, hypotrichosis, and hyper-ige 9.5
998 bardet-biedl syndrome 7 9.5
999 thrombocytopenia 5 9.5
1000 brown syndrome 9.5
1001 autoinflammatory syndrome, familial, behcet-like 9.5
1002 spastic paraplegia, intellectual disability, nystagmus, and obesity 9.5
1003 epidermodysplasia verruciformis 2 9.5
1004 encephalopathy, progressive, early-onset, with episodic rhabdomyolysis 9.5
1005 tendinopathy 9.5
1006 pulmonary hypertension 9.5
1007 adrenal cortical carcinoma 9.5
1008 hemophagocytic lymphohistiocytosis 9.5
1009 epstein-barr virus hepatitis 9.5
1010 variola major 9.5
1011 mantle cell lymphoma 9.5
1012 metabolic acidosis 9.5
1013 atrioventricular block 9.5
1014 peripheral artery disease 9.5
1015 renal fibrosis 9.5
1016 oral squamous cell carcinoma 9.5
1017 mucosal melanoma 9.5
1018 withdrawal disorder 9.5
1019 interleukin-7 receptor alpha deficiency 9.5
1020 autism spectrum disorder 9.5
1021 aphasia 9.5
1022 pharynx cancer 9.5
1023 microscopic colitis 9.5
1024 gastroduodenal crohn's disease 9.5
1025 basal ganglia calcification 9.5
1026 xanthinuria 9.5
1027 dowling-degos disease 9.5
1028 cardiac arrest 9.5
1029 anal fistula 9.5
1030 ectopic pregnancy 9.5
1031 acrodermatitis chronica atrophicans 9.5
1032 punctate palmoplantar keratoderma 9.5
1033 penicillin allergy 9.5
1034 recessive dystrophic epidermolysis bullosa 9.5
1035 physical disorder 9.5
1036 cryptococcal meningitis 9.5
1037 nodal marginal zone lymphoma 9.5
1038 x-linked chondrodysplasia punctata 2 9.5
1039 igg4-related disease 9.5
1040 hyper ige syndrome 9.5
1041 hypogonadotropic hypogonadism 9.5
1042 angioimmunoblastic t-cell lymphoma 9.5
1043 castleman disease 9.5
1044 asymptomatic neurosyphilis 9.5
1045 nodular malignant melanoma 9.5
1046 pigmentation disease 9.5
1047 keratoconus 9.5
1048 xerophthalmia 9.5
1049 thymus lymphoma 9.5
1050 neuroretinitis 9.5
1051 pleomorphic lipoma 9.5
1052 borderline leprosy 9.5
1053 parotitis 9.5
1054 legionellosis 9.5
1055 meningoencephalitis 9.5
1056 microphthalmia 9.5
1057 giardiasis 9.5
1058 methemoglobinemia 9.5
1059 kuhnt-junius degeneration 9.5
1060 dissociative disorder 9.5
1061 strongyloidiasis 9.5
1062 pseudopterygium 9.5
1063 pinguecula 9.5
1064 depersonalization disorder 9.5
1065 henoch-schoenlein purpura 9.5
1066 pertussis 9.5
1067 t cell deficiency 9.5
1068 disseminated intravascular coagulation 9.5
1069 social phobia 9.5
1070 arteriovenous malformation 9.5
1071 gingival recession 9.5
1072 autonomic nervous system disease 9.5
1073 hemopericardium 9.5
1074 suppurative otitis media 9.5
1075 hypertensive heart disease 9.5
1076 corneal abscess 9.5
1077 hyperandrogenism 9.5
1078 cicatricial pemphigoid 9.5
1079 nephrosclerosis 9.5
1080 familial hyperlipidemia 9.5
1081 portal vein thrombosis 9.5
1082 gestational diabetes 9.5
1083 lyme disease 9.5
1084 iron deficiency anemia 9.5
1085 pericardial effusion 9.5
1086 hemosiderosis 9.5
1087 dysthymic disorder 9.5
1088 paranoid schizophrenia 9.5
1089 graves' disease 9.5
1090 hepatitis a 9.5
1091 acute leukemia 9.5
1092 paracoccidioidomycosis 9.5
1093 locked-in syndrome 9.5
1094 leiomyoma 9.5
1095 quadriplegia 9.5
1096 hypochondriasis 9.5
1097 alcoholic cardiomyopathy 9.5
1098 conduct disorder 9.5
1099 carotid stenosis 9.5
1100 tinea unguium 9.5
1101 branch retinal artery occlusion 9.5
1102 central retinal artery occlusion 9.5
1103 crescentic glomerulonephritis 9.5
1104 cutaneous porphyria 9.5
1105 hairy tongue 9.5
1106 plantar wart 9.5
1107 familial hypercholesterolemia 9.5
1108 somatization disorder 9.5
1109 algoneurodystrophy 9.5
1110 folic acid deficiency anemia 9.5
1111 toxic labyrinthitis 9.5
1112 azoospermia 9.5
1113 chronic purulent otitis media 9.5
1114 sclerosing cholangitis 9.5
1115 cholinergic urticaria 9.5
1116 sporotrichosis 9.5
1117 labyrinthitis 9.5
1118 ectropion 9.5
1119 diffuse scleroderma 9.5
1120 rheumatic fever 9.5
1121 neovascular glaucoma 9.5
1122 peritoneum cancer 9.5
1123 epilepsy 9.5
1124 leiomyosarcoma 9.5
1125 rectum cancer 9.5
1126 vulvar disease 9.5
1127 essential thrombocythemia 9.5
1128 myeloproliferative neoplasm 9.5
1129 transient cerebral ischemia 9.5
1130 spondylosis 9.5
1131 keratopathy 9.5
1132 acromegaly 9.5
1133 thrombophilia 9.5
1134 blepharoconjunctivitis 9.5
1135 retinal vascular disease 9.5
1136 splenic abscess 9.5
1137 hematologic cancer 9.5
1138 hemangioma 9.5
1139 opiate dependence 9.5
1140 cervicitis 9.5
1141 tic disorder 9.5
1142 nonspecific interstitial pneumonia 9.5
1143 carbohydrate metabolic disorder 9.5
1144 breast ductal carcinoma 9.5
1145 early myoclonic encephalopathy 9.5
1146 skin squamous cell carcinoma 9.5
1147 tropical spastic paraparesis 9.5
1148 syringomyelia 9.5
1149 laryngitis 9.5
1150 retinitis 9.5
1151 anal canal adenocarcinoma 9.5
1152 vaginal discharge 9.5
1153 pleural empyema 9.5
1154 photoallergic dermatitis 9.5
1155 pituitary adenoma 9.5
1156 placental insufficiency 9.5
1157 insulinoma 9.5
1158 adrenal cortical adenocarcinoma 9.5
1159 merkel cell carcinoma 9.5
1160 eosinophilic gastroenteritis 9.5
1161 nodular basal cell carcinoma 9.5
1162 polyradiculoneuropathy 9.5
1163 tinea capitis 9.5
1164 amelanotic melanoma 9.5
1165 acneiform dermatitis 9.5
1166 neuromuscular disease 9.5
1167 hepatitis e 9.5
1168 clear cell renal cell carcinoma 9.5
1169 hypotrichosis 9.5
1170 mesenchymal chondrosarcoma 9.5
1171 extraskeletal mesenchymal chondrosarcoma 9.5
1172 multiple chemical sensitivity 9.5
1173 mongolian spot 9.5
1174 somatoform disorder 9.5
1175 angiokeratoma 9.5
1176 sebaceous adenocarcinoma 9.5
1177 epidermolysis bullosa dystrophica 9.5
1178 intestinal disease 9.5
1179 paget's disease of bone 9.5
1180 lung oat cell carcinoma 9.5
1181 schizoaffective disorder 9.5
1182 dystonia 9.5
1183 tricuspid valve prolapse 9.5
1184 pulmonary valve stenosis 9.5
1185 spinal stenosis 9.5
1186 lung lymphoma 9.5
1187 hepatoblastoma 9.5
1188 acth-secreting pituitary adenoma 9.5
1189 subacute thyroiditis 9.5
1190 diverticulitis 9.5
1191 muscular atrophy 9.5
1192 delusional disorder 9.5
1193 osteochondrosis 9.5
1194 myocarditis 9.5
1195 extrinsic allergic alveolitis 9.5
1196 cyclothymic disorder 9.5
1197 pellagra 9.5
1198 retinal artery occlusion 9.5
1199 sezary's disease 9.5
1200 lichen nitidus 9.5
1201 duodenitis 9.5
1202 gastroduodenitis 9.5
1203 substance-induced psychosis 9.5
1204 tongue cancer 9.5
1205 vascular dementia 9.5
1206 smallpox 9.5
1207 rubella 9.5
1208 cervix uteri carcinoma in situ 9.5
1209 ritter's disease 9.5
1210 macroglobulinemia 9.5
1211 ocular hypertension 9.5
1212 mechanical strabismus 9.5
1213 orbital plasma cell granuloma 9.5
1214 exophthalmos 9.5
1215 epiglottitis 9.5
1216 acute myocardial infarction 9.5
1217 intracranial hypertension 9.5
1218 otitis externa 9.5
1219 bronchiectasis 9.5
1220 necrotizing fasciitis 9.5
1221 biliary tract disease 9.5
1222 hypersensitivity vasculitis 9.5
1223 polyarteritis nodosa 9.5
1224 miliary tuberculosis 9.5
1225 toxoplasmosis 9.5
1226 albinism 9.5
1227 bap1 tumor predisposition syndrome 9.5
1228 c3 glomerulopathy 9.5
1229 cleidocranial dysplasia spectrum disorder 9.5
1230 47, xxy 9.5
1231 acquired hemophilia a 9.5
1232 acute articular rheumatism 9.5
1233 alopecia totalis 9.5
1234 aminoaciduria 9.5
1235 cataract-glaucoma 9.5
1236 cervical intraepithelial neoplasia 9.5
1237 demodicidosis 9.5
1238 drug reaction with eosinophilia and systemic symptoms 9.5
1239 erythroplakia 9.5
1240 exercise-induced anaphylaxis 9.5
1241 familial episodic pain syndrome 9.5
1242 familial glucocorticoid deficiency 9.5
1243 fibromatosis 9.5
1244 gigantism 9.5
1245 glucagonoma 9.5
1246 grover's disease 9.5
1247 hemorrhagic proctocolitis 9.5
1248 htlv-1 associated myelopathy/tropical spastic paraparesis 9.5
1249 keratosis follicularis spinulosa decalvans 9.5
1250 kikuchi disease 9.5
1251 lewis-sumner syndrome 9.5
1252 lichen planus pemphigoides 9.5
1253 lichen planus pigmentosus 9.5
1254 linear iga disease 9.5
1255 malakoplakia 9.5
1256 mercury poisoning 9.5
1257 mondor disease 9.5
1258 mycobacterium fortuitum 9.5
1259 oncogenic osteomalacia 9.5
1260 papular mucinosis 9.5
1261 periodontal ehlers-danlos syndrome 9.5
1262 pityriasis lichenoides et varioliformis acuta 9.5
1263 precocious puberty 9.5
1264 pseudo-turner syndrome 9.5
1265 retroperitoneal fibrosis 9.5
1266 scleromyxedema 9.5
1267 secondary adrenal insufficiency 9.5
1268 spastic paraparesis 9.5
1269 t-cell/histiocyte rich large b cell lymphoma 9.5
1270 childhood myocerebrohepatopathy spectrum 9.5
1271 hereditary xanthinuria 9.5
1272 atrial fibrillation and stroke 9.5
1273 dysphagia 9.5
1274 foot drop 9.5
1275 hereditary neuropathies 9.5
1276 hypotonia 9.5
1277 porokeratotic eccrine ostial and dermal duct nevus 9.5
1278 chronic cutaneous lupus erythematosus 9.5
1279 rare rheumatologic disease 9.5
1280 acute transverse myelitis 9.5
1281 cerebrofacial arteriovenous metameric syndrome 9.5
1282 nevus of ota 9.5
1283 pulmonary arterial hypertension associated with another disease 9.5
1284 herpetiform pemphigus 9.5
1285 primary cutaneous lymphoma 9.5
1286 isoniazid toxicity 9.5
1287 idiopathic nephrotic syndrome 9.5
1288 phalangeal microgeodic syndrome 9.5
1289 epstein-barr virus-associated malignant lymphoproliferative disorder 9.5
1290 myospherulosis 9.5
1291 acquired methemoglobinemia 9.5
1292 cutaneous pseudolymphoma 9.5
1293 chronic enteropathy associated with slco2a1 gene 9.5
1294 polyarticular juvenile idiopathic arthritis 9.5
1295 deep dermatophytosis 9.5
1296 zinc-responsive necrolytic acral erythema 9.5
1297 epidermolytic nevus 9.5
1298 granulomatous mastitis 9.5
1299 argyria 9.5
1300 disorder of purine metabolism 9.5
1301 rare genetic skin disease 9.5
1302 lichen amyloidosis 9.5
1303 serotonin syndrome 9.5
1304 superficial pemphigus 9.5
1305 obsolete: methotrexate poisoning 9.5
1306 renal dysplasia 9.5
1307 discrete papular lichen myxedematosus 9.5
1308 premature aging 9.5
1309 pemphigus erythematosus 9.5
1310 inherited epidermolysis bullosa 9.5
1311 hereditary palmoplantar keratoderma 9.5
1312 acrokeratoderma 9.5
1313 hepatosplenic t-cell lymphoma 9.5
1314 cardiogenic shock 9.5
1315 type ii mixed cryoglobulinemia 9.5
1316 uremic pruritus 9.5
1317 refractory anemia 9.5
1318 aggressive periodontitis 9.5 TNF IL1RN IL17A CXCL8
1319 brucellosis 9.5 TNF IL1RN IL17A CXCL8
1320 silicosis 9.5 TNF IL1RN IL17A CXCL8
1321 pneumoconiosis 9.5 TNF IL1RN IL17A CXCL8
1322 gingival disease 9.4 TNF SIGLEC5 IL17A CXCL8 CCR6
1323 parasitic protozoa infectious disease 9.4 TNF SIGLEC5 IL17A CXCL8 CCR6
1324 bronchial disease 9.4 TNF SIGLEC5 IL17A CXCL8 CCR6
1325 scleral disease 9.4 TNFRSF1B TNF MRAP IL1RN IL17A CCR6
1326 autoimmune disease of musculoskeletal system 9.2 TNFRSF1B TNF SIGLEC5 IL17A CXCL8 CCR6
1327 primary bacterial infectious disease 9.2 TNFRSF1B TNF SIGLEC5 IL17A CXCL8 CCR6
1328 conjunctival disease 9.1 TNF MRAP IL1RN IL17A CXCL8 CCR6
1329 hypersensitivity reaction type iv disease 8.9 TNFRSF1B TNF MRAP IL1RN IL17A CXCL8
1330 uveal disease 8.9 TNFRSF1B TNF MRAP IL1RN IL17A CXCL8
1331 sebaceous gland disease 8.8 TNF SIGLEC5 PSTPIP2 LPIN2 IL1RN CXCL8

Graphical network of the top 20 diseases related to Pustulosis of Palm and Sole:



Diseases related to Pustulosis of Palm and Sole

Symptoms & Phenotypes for Pustulosis of Palm and Sole

UMLS symptoms related to Pustulosis of Palm and Sole:


pruritus, exanthema, psoriasiform rash

MGI Mouse Phenotypes related to Pustulosis of Palm and Sole:

45 (showing 3, show less)
# Description MGI Source Accession Score Top Affiliating Genes
1 hematopoietic system MP:0005397 9.85 CCR6 GPRIN1 IL17A IL1RL2 IL1RN IL36RN
2 immune system MP:0005387 9.7 CARD14 CCR6 GPRIN1 IL17A IL1RL2 IL1RN
3 integument MP:0010771 9.23 CARD14 IL17A IL1RL2 IL1RN IL36RN PSTPIP2

Drugs & Therapeutics for Pustulosis of Palm and Sole

Drugs for Pustulosis of Palm and Sole (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(showing 459, show less)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Esomeprazole Approved, Investigational Phase 4 161796-78-7, 161973-10-0, 119141-88-7 9568614 4594
2
Dapsone Approved, Investigational Phase 4 80-08-0 2955
3
Clobetasol Approved, Experimental, Investigational Phase 4 25122-46-7, 25122-41-2 32798 5311051
4
Fluticasone Approved, Experimental Phase 4 90566-53-3 62924
5
Clocortolone Approved Phase 4 4828-27-7, 34097-16-0 5282493 5311052
6
Guaifenesin Approved, Investigational, Vet_approved Phase 4 93-14-1 3516
7
Sodium citrate Approved, Investigational Phase 4 68-04-2
8
Mannitol Approved, Investigational Phase 4 69-65-8 453 6251
9
carbamide peroxide Approved Phase 4 124-43-6
10 Orange Approved Phase 4
11 Artichoke Approved Phase 4
12 Strawberry Approved Phase 4
13
Sorafenib Approved, Investigational Phase 4 284461-73-0 216239 406563
14 Brodalumab Approved, Investigational Phase 4 1174395-19-7
15
Adalimumab Approved Phase 4 331731-18-1 16219006
16
Certolizumab pegol Approved Phase 4 428863-50-7
17
Desoximetasone Approved Phase 4 382-67-2 5311067
18
Abatacept Approved Phase 4 332348-12-6 10237
19
Tofacitinib Approved, Investigational Phase 4 477600-75-2
20
Zinc Approved, Investigational Phase 4 7440-66-6 32051
21
Mercaptopurine Approved Phase 4 50-44-2 667490
22
Aspirin Approved, Vet_approved Phase 4 50-78-2 2244
23
Sotalol Approved Phase 4 959-24-0, 3930-20-9 5253
24 Ixekizumab Approved, Investigational Phase 4 1143503-69-8
25
Ustekinumab Approved, Investigational Phase 4 815610-63-0
26
Metformin Approved Phase 4 657-24-9 14219 4091
27 Vedolizumab Approved Phase 4 943609-66-3
28
Betamethasone Approved, Vet_approved Phase 4 378-44-9 9782
29
Miconazole Approved, Investigational, Vet_approved Phase 4 22916-47-8 4189
30
Salicylic acid Approved, Investigational, Vet_approved Phase 4 69-72-7 338
31
Capsaicin Approved Phase 4 404-86-4 1548943
32
Vitamin A Approved, Nutraceutical, Vet_approved Phase 4 68-26-8, 11103-57-4, 22737-96-8 445354 9904001
33
Citric acid Approved, Nutraceutical, Vet_approved Phase 4 77-92-9 311
34
Glycine Approved, Nutraceutical, Vet_approved Phase 4 56-40-6 750